Nima Nassiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nima Nassiri has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
- Giovanni Enrico Cacciamani
USC Institute of Urology, University of Southern California, Los Angeles, USA
5 shared publications Marissa Maas
USC Institute of Urology and Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Artificial Intelligence Center at USC Urology, USC Institute of Urology, University of Southern California, Los Angeles, CA, USA
5 shared publicationsKian Asanad
Department of Urology, Los Angeles County + University of Southern California Medical Center, Los Angeles, CA, USA; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
4 shared publicationsInderbir S. Gill
Catherine & Joseph Aresty Department of Urology
3 shared publications- Inderbir S. Gill
USC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA
3 shared publications - Kian Asanad
Keck School of Medicine of USC, University of Southern California Institute of Urology, Los Angeles, CA 90089, USA
3 shared publications
Latest Publications
- 25 September 2026
- Published by Elsevier in American Journal of Transplantation
Open recovery of the vascularized composite bladder allograft for bladder transplantation
- 25 September 2026
- Published by Elsevier in American Journal of Transplantation
Open recovery of the vascularized composite bladder allograft for bladder transplantation
- Open Access
- 19 September 2026
- Published by Elsevier in American Journal of Transplantation
Delayed immune tolerance intentionally achieved years after 2-haplotype matched kidney transplantation
- 19 September 2026
- Published by Elsevier in American Journal of Transplantation
Open AccessDelayed immune tolerance intentionally achieved years after 2-haplotype matched kidney transplantation
- 1 October 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 210 (4) , 600-610
Robotic Bladder Autotransplantation: Preclinical Studies in Preparation for First-in-human Bladder Transplant
Human urinary bladder transplantation has never been performed. From a technical standpoint, challenges include the complex deep pelvic vascular anatomy, limited intraoperative visualization, and high procedural complexity. In preparation for a first-in-human clinical trial, we report preclinical studies to develop the technique of robotic retrieval and autotransplantation of vascularized composite bladder allograft. Institutional Animal Care and Use Committee, Institutional Review Board, and UNOS (United Network for Organ Sharing) approvals were obtained, and IDEAL (Idea, Development, Exploration, Assessment, Long-term Study) Reporting Guidelines were followed. Robotic vascularized composite bladder allograft recovery, back-table graft preparation, and robotic autotransplantation were performed in 3 vascularized model settings: living porcine (n=3), pulsatile human cadavers (n=2), and heart-beating brain-dead deceased research human donors (n=5). Our primary objective was to develop a reproducible technique for robotic vascularized composite bladder allograft transplantation. Technical success was defined by adequate, sustained vascularized composite bladder allograft reperfusion. Secondary objectives were intraoperative parameters, including operative time, graft ischemia time, and blood loss. Successful robotic vascularized composite bladder allograft autotransplantation was achieved in 2 porcine, 1 cadaver, and 3 brain-dead research donors. In the heart-beating research donors, console time decreased with successive surgeries, and visual inspection revealed healthy revascularized autografts with prompt, global indocyanine green immunofluorescence uptake. In 1 heart-beating donor who was hemodynamically maintained for 12 hours postoperatively, reinspection confirmed excellent maintained global vascularized composite bladder allograft vascularity and bladder mucosal integrity. To our knowledge, the first preclinical experience of bladder autotransplantation in vascularized models is reported, including robotic vascularized composite bladder allograft recovery, back-table reconstruction, and autotransplantation. This experience represents the essential preclinical work required to build toward the first-in-human trial of bladder transplantation, performed under a UNOS-approved genitourinary vascularized composite bladder allograft program (NCT No. 05462561).
- 1 October 2023
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 210 (4) , 600-610
Robotic Bladder Autotransplantation: Preclinical Studies in Preparation for First-in-human Bladder Transplant
Human urinary bladder transplantation has never been performed. From a technical standpoint, challenges include the complex deep pelvic vascular anatomy, limited intraoperative visualization, and high procedural complexity. In preparation for a first-in-human clinical trial, we report preclinical studies to develop the technique of robotic retrieval and autotransplantation of vascularized composite bladder allograft. Institutional Animal Care and Use Committee, Institutional Review Board, and UNOS (United Network for Organ Sharing) approvals were obtained, and IDEAL (Idea, Development, Exploration, Assessment, Long-term Study) Reporting Guidelines were followed. Robotic vascularized composite bladder allograft recovery, back-table graft preparation, and robotic autotransplantation were performed in 3 vascularized model settings: living porcine (n=3), pulsatile human cadavers (n=2), and heart-beating brain-dead deceased research human donors (n=5). Our primary objective was to develop a reproducible technique for robotic vascularized composite bladder allograft transplantation. Technical success was defined by adequate, sustained vascularized composite bladder allograft reperfusion. Secondary objectives were intraoperative parameters, including operative time, graft ischemia time, and blood loss. Successful robotic vascularized composite bladder allograft autotransplantation was achieved in 2 porcine, 1 cadaver, and 3 brain-dead research donors. In the heart-beating research donors, console time decreased with successive surgeries, and visual inspection revealed healthy revascularized autografts with prompt, global indocyanine green immunofluorescence uptake. In 1 heart-beating donor who was hemodynamically maintained for 12 hours postoperatively, reinspection confirmed excellent maintained global vascularized composite bladder allograft vascularity and bladder mucosal integrity. To our knowledge, the first preclinical experience of bladder autotransplantation in vascularized models is reported, including robotic vascularized composite bladder allograft recovery, back-table reconstruction, and autotransplantation. This experience represents the essential preclinical work required to build toward the first-in-human trial of bladder transplantation, performed under a UNOS-approved genitourinary vascularized composite bladder allograft program (NCT No. 05462561).
- 15 September 2023
- Published by Elsevier in European Urology
- Vol. 84 (5) , e121-e122
Reply to Laura E. Davis, Adam Calaway, and Laura Bukavina’s Letter to the Editor re: Nima Nassiri, Giovanni Cacciamani, Inderbir S. Gill. Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor. Eur Urol. 2023;84:517–518
- 15 September 2023
- Published by Elsevier in European Urology
- Vol. 84 (5) , e121-e122
Reply to Laura E. Davis, Adam Calaway, and Laura Bukavina’s Letter to the Editor re: Nima Nassiri, Giovanni Cacciamani, Inderbir S. Gill. Robotic Bladder Auto-transplantation in a Heart-beating Brain-dead Human Research Donor. Eur Urol. 2023;84:517–518
- Open Access
- 28 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e27396
Hyperandrogenism and Hyperestrogenism Secondary to Mixed Germ-Cell Testicular Tumor
Testicular cancer with androgen and estrogen secretion is classically associated with Leydig cell tumors. Rare case reports have described this finding in germ-cell tumors along with signs of androgen and estrogen excess including gynecomastia and infertility. We report the case of a 19-year-old male with a non-seminomatous testicular germ-cell tumor found to have hyperandrogenism, hyperestrogenism, and suppression of central sex hormones. Similar findings may be underreported in the literature, and males with suspected testicular malignancy should be appropriately screened for signs of androgen and/or estrogen excess so they can be offered appropriate monitoring and counseling.
- 28 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e27396
Open AccessHyperandrogenism and Hyperestrogenism Secondary to Mixed Germ-Cell Testicular Tumor
Testicular cancer with androgen and estrogen secretion is classically associated with Leydig cell tumors. Rare case reports have described this finding in germ-cell tumors along with signs of androgen and estrogen excess including gynecomastia and infertility. We report the case of a 19-year-old male with a non-seminomatous testicular germ-cell tumor found to have hyperandrogenism, hyperestrogenism, and suppression of central sex hormones. Similar findings may be underreported in the literature, and males with suspected testicular malignancy should be appropriately screened for signs of androgen and/or estrogen excess so they can be offered appropriate monitoring and counseling.
- 1 July 2022
- Published by Elsevier in European Urology Focus
- Vol. 8 (4) , 988-994
A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma
- 1 July 2022
- Published by Elsevier in European Urology Focus
- Vol. 8 (4) , 988-994
A Radiomic-based Machine Learning Algorithm to Reliably Differentiate Benign Renal Masses from Renal Cell Carcinoma
- 1 January 2022
- Published by Springer Nature
- p. 217-226
Preoperative Setting-Up of Patients Undergoing Robotic Inferior Vena Cava Thrombectomy
- 1 January 2022
- Published by Springer Nature
- p. 217-226
Preoperative Setting-Up of Patients Undergoing Robotic Inferior Vena Cava Thrombectomy
- 2 November 2021
- Published by Springer Nature
- p. 261-272
Retroperitoneal District: Approaches to Renal Diseases
- 2 November 2021
- Published by Springer Nature
- p. 261-272
Retroperitoneal District: Approaches to Renal Diseases